Menin and its interacting proteins: elucidation of menin function

Trends in Endocrinology and Metabolism

Volumn 17, Issue 9, 2006, Pages 357-364

  Balogh, Katalin ^a   Rácz, Károly ^a   Patócs, Attila ^a   Hunyady, László ^b  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA GROUP D2 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METHIONINE; PROTEIN; PROTEIN DERIVATIVE; REPLICATION PROTEIN A; SOMATOMEDIN BINDING PROTEIN 2; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR JUND; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BONE DEVELOPMENT; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; ENDOCRINE TUMOR; GENE; GENOMIC INSTABILITY; HEMATOPOIESIS; HYPOPHYSIS; MESENCHYMAL STEM CELL; MULTIPLE ENDOCRINE NEOPLASIA; NONHUMAN; PANCREAS; PARATHYROID GLAND; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; TUMOR SUPPRESSOR GENE;

BONE DEVELOPMENT; ENDOCRINE GLAND NEOPLASMS; HEMATOPOIESIS; HUMANS; MODELS, BIOLOGICAL; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS;

EID: 33750075037     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tem.2006.09.004     Document Type: Review

References (43)

1. Guru S.C., et al. Identification and characterization of the multiple endocrine neoplasia type 1 (MEN1) gene. J. Intern. Med. 243 (1998) 433-439
2. Guru S.C., et al. Menin, the product of the MEN1 gene, is a nuclear protein. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 1630-1634
3. Marx S.J., and Simonds W.F. Hereditary hormone excess: genes, molecular pathways, and syndromes. Endocr. Rev. 26 (2005) 615-661
4. Thakker R.V. Multiple endocrine neoplasia. Horm. Res. 56 Suppl. 1 (2001) 67-72
5. Yaguchi H., et al. Menin missense mutants associated with multiple endocrine neoplasia type 1 are rapidly degraded via the ubiquitin-proteasome pathway. Mol. Cell. Biol. 24 (2004) 6569-6580
6. Poisson A., et al. Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1. Cancer Lett. 189 (2003) 1-10
7. La P., et al. Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2. Endocrinology 145 (2004) 3443-3450
8. Yaguchi H., et al. Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J. Biol. Chem. 277 (2002) 38197-38204
9. La P., et al. Direct binding of DNA by tumor suppressor menin. J. Biol. Chem. 279 (2004) 49045-49054
10. Kaji H., et al. Cell cycle regulation of menin expression. Cancer Res. 59 (1999) 5097-5101
11. Schnepp R.W., et al. Functional interaction between tumor suppressor menin and activator of S-phase kinase. Cancer Res. 64 (2004) 6791-6796
12. Huang S.C., et al. Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Lab. Invest. 79 (1999) 301-310
13. Suphapeetiporn K., et al. MEN1 tumor-suppressor protein localizes to telomers during meiosis. Genes Chromosomes Cancer 35 (2002) 81-85
14. Lin S.Y., and Elledge S.J. Multiple tumor suppressor pathways negatively regulate telomerase. Cell 113 (2003) 881-889
15. Lopez-Egido J., et al. Menin's interaction with glial fibrillary acidic protein and vimentin suggests a role for the intermediate filament network in regulating menin activity. Exp. Cell Res. 278 (2002) 175-183
16. Jin S., et al. Menin associates with FANCD2, a protein involved in repair of DNA damage. Cancer Res. 63 (2003) 4204-4210
17. Milne T.A., et al. Menin and MLL cooperatively regulate expression of cyclin-dependent kimase inhibitors. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 749-754
18. Yokoyama A., et al. Leukemia proto-oncoprotein MLL forms a SET1-like histone methyltransferase complex with menin to regulate Hox gene expression. Mol. Cell. Biol. 24 (2004) 5639-5649
19. Yazgan O., and Pfarr C.M. Differential binding of the menin tumor suppressor protein to JunD isoforms. Cancer Res. 61 (2001) 916-920
20. Agarwal S.K., et al. Transcription factor JunD, deprived of menin, switches from growth suppressor to growth promoter. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 10770-10775
21. Dockray G.J. Keeping neuroendocrine cells in check: roles for TGFβ, Smads and menin?. Gut 52 (2003) 1237-1239
22. Ratineau C., et al. Reduction of menin expression enhances cell proliferation and is tumorigenic in intestinal epithelial cells. J. Biol. Chem. 279 (2004) 24477-24484
23. Kaji H., et al. Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type β signaling. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 3837-3842
24. Scappaticci S., et al. Chromosome abnormalities in lymphocytes and fibroblasts of subjects with multiple endocrine neoplasia type 1. Cancer Genet. Cytogenet. 52 (1991) 85-92
25. Sukhodolets K.E., et al. The 32-kilodalton subunit of replication protein A interacts with menin, the product of the MEN1 tumor suppressor gene. Mol. Cell. Biol. 23 (2003) 493-509
26. Heppner C., et al. The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation. Oncogene 20 (2001) 4917-4925
27. Hughes C.M., et al. Menin associates with trithorax family histone methyltransferase complex and with hox8 locus. Mol. Cell 13 (2004) 587-597
28. Kim H., et al. Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex. Cancer Res. 63 (2003) 6135-6139
29. Karnik S.K., et al. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 14659-14664
30. Bhuiyan M.M.R., et al. Expression of menin in parathyroid tumors. J. Clin. Endocrinol. Metab. 85 (2000) 2615-2619
31. Shattuck T.M., et al. Mutational analysis of Smad3, a candidate tumor suppressor implicated in TGF-β and menin pathways, in parathyroid adenomas and enteropancreatic endocrine tumors. J. Clin. Endocrinol. Metab. 87 (2002) 3911-3914
32. Sowa H., et al. Menin inactivation leads to loss of transforming growth factor β inhibition of parathyroid cell proliferation and parathyroid hormone secretion. Cancer Res. 64 (2004) 2222-2228
33. Farrell W.E., and Clayton R.N. Molecular pathogenesis of pituitary tumors. Front. Neuroendocrinol. 21 (2000) 174-198
34. Satta M.A., et al. Expression of menin gene mRNA in pituitary tumors. Eur. J. Endocrinol. 140 (1999) 358-361
35. Lacerte A., et al. Activin inhibits pituitary prolactin expression and cell growth though Smads, Pit-1 and menin. Mol. Endocrinol. 18 (2004) 1558-1569
36. Namihira H., et al. The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity. J. Mol. Endocrinol. 29 (2002) 297-304
37. ATP) connection. Diabetes 54 (2005) 3065-3072
38. Cavallari I., et al. In situ analysis of human menin in normal and neoplastic pancreatic tissues: evidence for differential expression in exocrine and endocrine cells. J. Clin. Endocrinol. Metab. 88 (2003) 3893-3901
39. Sayo Y., et al. The multiple endocrine neoplasia type 1 gene product, menin, inhibits insulin production in rat insulinoma cells. Endocrinology 143 (2002) 2347-2440
40. Hendy G.N., et al. Menin and TGF-β superfamily member signaling via the Smad pathway in pituitary, parathyroid and osteoblast. Horm. Metab. Res. 37 (2005) 375-379
41. Sowa H., et al. Menin is required for bone morphogenetic protein 2- and transforming growth factor β-regulated osteoblastic differentiation through interaction with Smads and Runx2. J. Biol. Chem. 279 (2004) 40267-40275
42. Naito J. Menin suppresses osteoblast differentiation by antagonizing the AP-1 factor, JunD. J. Biol. Chem. 280 (2005) 4785-4791
43. Chen Y.-X., et al. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 1018-1023